Search concepts
|
Selected filters
|
- 5,900 - 5,950 out of 7,046 results
- Export search results
Search results
-
PQ-110-001: A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of EXN407 in Subjects with Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Merani, R., Tan, P. & Chapman, N.
20/01/21 → 19/01/24
Project: Research
-
CHARIOT: A phase II study evaluating efficacy and safety of Ipilimumab and Nivolumab with neoadjuvant weekly paclitaxel after anthracycline based chemotherapy in high-risk primary triple negative breast cancer, followed by definitive surgery and one year total duration of Nivolumab
Kefford, R. & Cunningham, J.
6/03/19 → 23/01/24
Project: Other
-
TOPCHILD (Transforming Obesity Prevention for CHILDren). Looking at evidence based interventions
1/01/20 → 31/01/24
Project: Research
-
DP220102267: DP220102267 - Hyperfractals for Scalable and Effective Urban Digital Twins
1/01/22 → 31/01/24
Project: Research
File -
-
-
UWA led: CRISPR-based pathway activation for bioactive molecule discovery in fungi
Chooi, Y. H., Piggott, A. & Keller, N.
11/02/21 → 10/02/24
Project: Research
-
CDU led: Skin Microbes and Animal Health: Understanding the Ecological Context
Christian, K., Gibb, K. S. & Brown, G.
15/02/21 → 14/02/24
Project: Research
-
SUT led : Context-aware verification and validation framework for autonomous driving
Chen, T., Vu, H., Liu, H., Zheng, J. & Zhou, Z.
25/02/21 → 24/02/24
Project: Research
-
A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
Gurney, H., Chapman, N. & Butala, R.
28/02/19 → 27/02/24
Project: Other
-
The impact of climate on sorghum utilisation in poultry diet
Liu, S. Y., Selle, P. H., McQuade, L., McInerney, B. & Godwin, I.
30/09/20 → 29/02/24
Project: Research
-
SQA: Large Baseline Quantum Networks for Super-Resolution Imaging
Brennen, G. & Huang, Z.
1/03/21 → 29/02/24
Project: Research
-
New tools, methods, and resources for aquatic symbioses
Llorente, B., Paulsen, I., Bapteste, E., Mitchell, L. A. & Escalante, R.
1/09/20 → 1/03/24
Project: Research
-
DP21: Laser emission at the limit of glass transparency using nanocrystal doping
Jackson, S., Ebendorff-Heidepriem, H. & Lu, Y.
10/03/21 → 9/03/24
Project: Research
-
CDU Led : Collaborative science for monitoring of Northern Territory marine megafauna
Banks, S., Harcourt, R., Day, J., Udyawer, V., Grech, A., Kent, C. S., Smith, B., Moyle, F., McAdam, D., Buckworth, R. C. & Burton, D.
10/03/21 → 9/03/24
Project: Research
-
DP21: The link between cratonic roots, redox state, and mantle geodynamics
O'Neill, C. J., Hansen, S., O'Reilly, S., Griffin, B. & Begg, G.
10/03/21 → 9/03/24
Project: Research
-
UTS led: Climate impacts on grass phenology, biodiversity and pollen exposure
Huete, A. R., Davies, J., Beggs, P. & Miura, T.
11/03/21 → 10/03/24
Project: Research
-
A Phase II Trial of single agent CABOZANTINIB in patients with locally advanced or metastatic non-clear cell renal cell carcinoma post immunotherapy or who are unsuitable for immunotherapy (ANZUP 1802)
Gurney, H., Chapman, N., Cunningham, J. & Butala, R.
14/03/19 → 13/03/24
Project: Other
-
A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE)
Sabanathan, D., Kefford, R. & Cunningham, J.
21/03/19 → 20/03/24
Project: Other
-
Global patterns of mammalian biodiversity loss over the last 50,000 years
Alroy, J., Brook, B. W. & Lyons, S.
22/03/21 → 21/03/24
Project: Research
-
UTS led: Pushing the digital limits in quantum simulation for advanced manufacturing
Langford, N., Dehollain, J., Burgarth, D., Berry, D. & Heyl, M.
26/03/21 → 25/03/24
Project: Research
-
DP21: Dusty models of stellar outbursts triggered by stellar interactions
De Marco, O., Seiss, L. & Kasliwal, M.
30/03/21 → 29/03/24
Project: Research
-
-
Investigating the role of demyelination in anterograde transsynaptic degeneration in MS
1/04/20 → 31/03/24
Project: Research
-
UNSW led : Robust Preference Inference from Spatial-Temporal Interaction Networks
Yao, L., Sheng, M. & Benatallah, B.
1/04/21 → 31/03/24
Project: Research
-
Sydney Quantum Academy PhD Top-Up Scholarship_Burgarth/Hahn
Hahn, A., Burgarth, D. & Brennen, G.
1/03/20 → 31/03/24
Project: Research
-
TTVF: Transitioning Taranaki to a Volcanic Future
Turner, S. & Cronin, S. J.
28/10/19 → 31/03/24
Project: Research
File -
-
Monash Led: Quantifying the threat posed by feral cats to Australian reptiles
Chapple, D. G., Moseby, K., Nimmo, D., Doherty, T. & Carthey, A.
12/04/21 → 11/04/24
Project: Research
-
Building a Lifeline for the future: Expectations, innovations, outcomes
Rickwood, D., Titov, N., Pirkis, J., Klein, B., Batterham, P. J., Epps, J. R., Goecke, R., Kolves, K., Gould, M. & Bradford, S.
1/05/19 → 30/04/24
Project: Other
-
DYNAMIC III: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study
Poursoltan, P., Chapman, N. & Cunningham, J.
2/05/19 → 1/05/24
Project: Other
-
GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
30/09/19 → 7/05/24
Project: Research
-
A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma
Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.
16/05/19 → 15/05/24
Project: Other
-
A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma
Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.
16/05/19 → 15/05/24
Project: Other
-
Unveiling the Milky Way Galaxy: dense gas structure and star formation
Breen, S. & Dawson, J.
20/05/20 → 19/05/24
Project: Other
-
ARC FT: The Mangatharra Road: a documentary-film history of first Australian trade
20/05/20 → 19/05/24
Project: Other
-
KEYLYNK-010: A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration resistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment with One Next-generation Hormonal Agent (NHA) and Chemotherapy
Gurney, H., Butala, R. & Chapman, N.
9/09/19 → 30/05/24
Project: Other
-
KEYNOTE-641: Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Gurney, H., Chapman, N. & Butala, R.
8/08/19 → 5/06/24
Project: Other
-
KEYNOTE-905: A Phase 3 Randomized Study of Cystectomy plus Perioperative Pembrolizumab versus Cystectomy Alone in Cisplatin-ineligible Participants with Muscle-invasive Bladder Cancer (MK3475-905)
Zhang, A., Chapman, N. & Parshionikar, A.
13/09/19 → 6/06/24
Project: Other
-
LEAP-011: A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression: Protocol MK7902-011-00
Zhang, A., Butala, R. & Chapman, N.
13/09/19 → 6/06/24
Project: Research
-
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
Zhang, A., Chapman, N. & Butala, R.
6/08/19 → 18/06/24
Project: Other
-
The evolution of host-parasite interactions during a biological invasion
Shine, R. & Rollins, L.
26/06/19 → 25/06/24
Project: Other
-
A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer
Gurney, H., Chapman, N. & Butala, R.
5/08/19 → 26/06/24
Project: Other
-
An EVT Approach to Modeling Joint Extremes in Climate and Mortality
Li, H. & Tang, Q.
9/07/19 → 8/07/24
Project: Research
-
VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Leong, R., Butala, R. & Chapman, N.
24/09/19 → 11/07/24
Project: Other
-
COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk
Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
2/10/19 → 11/07/24
Project: Other
-
COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk
Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
2/10/19 → 11/07/24
Project: Other
-